reuptake inhibitor

Depression Treatment: Poor Sleep in Patients With Multiple Sclerosis.

Poor sleep in patients with multiple sclerosis.

Filed under: Depression Treatment

PLoS One. 2012; 7(11): e49996
Bøe Lunde HM, Aae TF, Indrevåg W, Aarseth J, Bjorvatn B, Myhr KM, Bø L

Poor sleep is a frequent symptom in patients with multiple sclerosis (MS). Sleep may be influenced by MS-related symptoms and adverse effects from immunotherapy and symptomatic medications. We aimed to study the prevalence of poor sleep and the influence of socio-demographic and clinical factors on sleep quality in MS- patients.A total of 90 MS patients and 108 sex-and age- matched controls were included in a questionnaire survey. Sleep complaints were evaluated by Pittsburgh Sleep Quality Index (PSQI) and a global PSQI score was used to separate good sleepers (?5) from poor sleepers (>5). Excessive daytime sleepiness, the use of immunotherapy… Continue reading

Depression: The Use of Medication for Depression


 

Depression: The use of Medication for Depression – www.dragresti.com ~ (561) 842-9550 Dr. Agresti, Psychiatrist in West Palm Beach, Florida, talks about his preferred medications for treating depression. Depression is more that just feeling sad for a few days.… Continue reading

Association of Tef Polymorphism With Depression in Parkinson Disease.

Association of Tef polymorphism with depression in Parkinson disease.

Filed under: Depression Treatment

Mov Disord. 2012 Nov 8;
Hua P, Liu W, Kuo SH, Zhao Y, Chen L, Zhang N, Wang C, Guo S, Wang L, Xiao H, Kwan… Continue reading

Depression Treatment: Vesicular Signalling and Immune Modulation as Hedonic Fingerprints: Proteomic Profiling in the Chronic Mild Stress Depression Model.

Vesicular signalling and immune modulation as hedonic fingerprints: proteomic profiling in the chronic mild stress depression model.

Filed under: Depression Treatment

J Psychopharmacol. 2012 Nov 8;
Bisgaard CF, Bak S, Christensen T, Jensen ON, Enghild JJ, Wiborg O

Extensive… Continue reading

Mayo Clinic Collaborative Research Focuses on Depression Treatments


 

Mayo Clinic Collaborative Research Focuses on Depression Treatments – Researchers at Mayo Clinics campus in Jacksonville and Virginia Tech in Blacksburg, Va., through their technology commercialization efforts, have licensed compounds to Astra Zeneca for potential new drug therapies to… Continue reading

Identification and Validation of Urinary Metabolite Biomarkers for Major Depressive Disorder.

Identification and validation of urinary metabolite biomarkers for major depressive disorder.

Filed under: Depression Treatment

Mol Cell Proteomics. 2012 Oct 30;
Zheng P, Wang Y, Chen L, Yang D, Meng H, Zhou D, Zhong J, Lei Y, Melgiri N,… Continue reading

Depression Treatment: Genetic Predictors of Response to Serotonergic and Noradrenergic Antidepressants in Major Depressive Disorder: A Genome-Wide Analysis of Individual-Level Data and a Meta-Analysis.

Genetic predictors of response to serotonergic and noradrenergic antidepressants in major depressive disorder: a genome-wide analysis of individual-level data and a meta-analysis.

Filed under: Depression Treatment

PLoS Med. 2012 Oct; 9(10): e1001326
Tansey KE, Guipponi M, Perroud N, Bondolfi… Continue reading

Depression Treatment: Effect of Selective Serotonin Reuptake Inhibitors in Alzheimer’s Disease With Comorbid Depression : A Meta-Analysis of Depression and Cognitive Outcomes.

Effect of selective serotonin reuptake inhibitors in Alzheimer’s disease with comorbid depression : a meta-analysis of depression and cognitive outcomes.

Filed under: Depression Treatment

Drugs Aging. 2012 Oct; 29(10): 793-806
Sepehry AA, Lee PE, Hsiung GY, Beattie BL, Jacova… Continue reading

Fears of Compassion and Happiness in Relation to Alexithymia, Mindfulness, and Self-Criticism.

Fears of compassion and happiness in relation to alexithymia, mindfulness, and self-criticism.

Filed under: Depression Treatment

Psychol Psychother. 2012 Dec; 85(4): 374-90
Gilbert P, McEwan K, Gibbons L, Chotai S, Duarte J, Matos M

Background.?There is increasing research to… Continue reading

PILOT RANDOMIZED TRIAL of a CROSS-DIAGNOSIS COLLABORATIVE CARE PROGRAM for PATIENTS WITH MOOD DISORDERS.

PILOT RANDOMIZED TRIAL OF A CROSS-DIAGNOSIS COLLABORATIVE CARE PROGRAM FOR PATIENTS WITH MOOD DISORDERS.

Filed under: Depression Treatment

Depress Anxiety. 2012 Oct 17;
Kilbourne AM, Li D, Lai Z, Waxmonsky J, Ketter T

OBJECTIVES: Chronic care models improved outcomes… Continue reading